第五届上海国际肿瘤局部与靶向治疗国际论坛暨第4届生物技术与仪器展
主办方: 复旦大学附属中山医院、复旦大学肝癌研究所、复旦大学上海医学院
活动时间: 2013-11-15 08:19 至 2013-11-18 19:19
协办方: 复旦大学附属肿瘤医院、复旦大学药学院、上海市临床检验中心
联系:

Sally

Tel: +86-21-5240 0455
Email: sally@biotechinstrument.org

费用: 3,000
地区: 上海
介绍

2013年11月15-18日在上海光大国际酒店举办的“第五届上海国际肿瘤局部与靶向治疗研讨会暨第四届最新生物技术与仪器展(RTTC2013)”。
RTTC2013是上海举办的高水平肿瘤检测与分型及靶向治疗国际学术会议,由复旦大学附属中山医院、复旦大学肝癌研究所、复旦大学上海医学院共同主办, 由复旦大学附属肿瘤医院、复旦大学药学院、上海市临床检验中心协办。参会者多数为各级医院医生、临床检验人员和大学、研究所的科研人员,以及来自制药企业、生物技术公司和医疗器械公司的相关人员。参加会议的正式代表可获得国家医学教育项目I类学分10分。会议的官方网址是:www.biotech-instrument.org 。
今年会议的亮点在于肿瘤诊断、分型以及靶向药物联合治疗,100余位世界顶尖科学家、医生和临床研究人员将通过大会及合作项目来展示他们的科研成果并分享科学发现。具体议程请参考http://www.biotech-instrument.org/dahuiyicheng/huiyiyicheng/
一、会议主题:共享信息 协同创新

随着基因组学研究的发展,科学家得以真正了解癌症的生物工作机理,这比科学家原本设想的更为复杂。以往攻克癌症的研究诊治模式,是否需要彻底变革?为了改善癌症病人的治疗成果和生活质量,“规范的综合治疗、诊疗个体化、预防和筛查”这些临床经验值得全球的政策制定者、医院、医疗保险和医药企业共同努力。与单个研究人员和医生专注于具体癌症研究和临床需求的传统方式相比,通过专家合作来解决主要癌症疾病的现存问题,群体科学可能更适合于抗击癌症。
大会组委会邀请了来自欧美、亚太、中国的近百位医生和科学家,通过主题演讲、交互式圆桌讨论、面对面会议等形式与大家分享肿瘤检测与分型,靶向药物治疗联合应用、全球抗肿瘤药物市场状况、下一代抗癌药物研发和临床试验研究等领域基础和临床的最新进展,医院、实验室创新工具及仪器对提升临床及试验研究的新机会,促进医院、科研单位和厂商公司之间的有效合作。
二、 会议内容:
第一天)2013年11月15日(星期五
专题研讨1:中美医疗合作项目--从创新到临床
专题研讨2:医疗领域未来的投融资趋势

第二天 2013年11月15日(星期五
大会报告
专题1:肿瘤检测和分型与肿瘤的个体化治疗
专题2:面临的挑战:分子诊断的市场前景
专题3:靶向治疗与放射治疗的前景和难题
专题4:肿瘤的分子显像与靶向性治疗
专题5:建立联系:如何与临床医生有效合作
专题6:靶向药物治疗的地位与联合应用

第三天2013年11月15日(星期五
大会报告
专题7:医院中心实验室科研发展与合作
专题8:从实验室到临床:医院中心实验室创新合作模式
专题9:个性化肿瘤学和下一代抗癌药物开发
专题10:在中国进行肿瘤临床试验研究
专题11:治疗耐受的预期及预后相关诊断
专题12:肿瘤干细胞治疗癌症的临床潜力

三、 大会注册费:


注册费 企业代表 国内医务、科研人员
提前注册(8月30前) 3000元/人 1500元/人
现场注册(11月15日) 4000元/人 2000元/人
备注:1. 注册费用包含参加所有会议主题讨论,现场会议资料,社交茶歇、午餐及社交鸡尾酒会、晚宴;;2.参会代表注册后如需正式邀请函请说明,会务组将提供正式会议邀请函给您;3.学生凭学生证可以享受半价优惠


四、 展览服务:
本届大会为制药、检验行业的厂商、服务商提供展览服务,设立肿瘤诊断专区,给药和治疗专区,生物技术产品专区,医疗器械专区和医院、实验室工具与仪器、试剂专区,具体可参考http://www.biotech-instrument.org/zhanlanxinxi/# 。

RTTC是一个非常好的学术推广平台,从2009年至今已连续举办了4届, 为科学家、医生和研究者提供学术对话和互相沟通与交流的平台,提升临床试验与研究水平,提供潜在的技术合作需求,积极推动医院、科研单位和医药公司之间的有效合作。
五、注册
1) 网页注册请参考:http://www.biotech-instrument.org/en/canhuizhuce/

2) 邮件注册: 请填写完附件中注册表后,发送至Sally@biotechinstrument.org

3) 传真注册: 请填写完附件中注册表后,传真至 +86-21-5240 0466



5th International Forum of Regional and Targeting Therapies for Cancer
15th-18th November 2013, Shanghai China
www.biotech-instrument.org


Dear Respected Colleagues and Friends,

On behalf of the Organizing Committee of the 5th Shanghai International Forum of Regional and Targeting Therapies for Cancer (RTTC2013), we are now extending our sincerely warm welcome to you to attend this important conference, which will be held during November 15-18, 2013 at Shanghai Everbright International hotel. We believe your talk will add brilliance and splendor to RTTC 2013.

This forum is one of the highest level international academic conferences on Tumor Detection and stratification as well as Targeting Therapy held in Shanghai. RTTC is organized by Zhongshan hospital affiliated to Fudan University, Liver Cancer Institute of Fudan University as well as Shanghai Medical College of Fudan University and is co-organized by Tumor Hospital affiliated to Fudan University, Pharmacy Faculty of Fudan University as well as Shanghai Clinical Test Center. Most of participators are doctors, clinical inspectors, researchers in universities and research institutes, as well as the related workers from pharmaceutical companies, biotechnology companies and medical instrument companies. Please refer to RTTC 2013official website: www.biotech-instrument.org.

The highlight of RTTC 2013 lies in tumor diagnosis, stratification and targeted drug combination therapy, (hospitals, laboratory innovative tools and instruments). More than 100 world famous scientists, physicians and clinical researchers will share their research findings as well as scientific discovery through meetings and collaborative projects. For more information, please go to http://www.biotech-instrument.org/dahuiyicheng/huiyiyicheng/.

Your support as well as your participation are greatly appreciated in advance. Shanghai has an invigorating autumn climate in November. Let's meat in Shanghai in 2013!


Conference Background

With the development of genomics research, scientists have gradually understood the biological mechanism of cancer. Compared with the traditional way in which individual researcher or physician focuses on the specific cancer research and clinical needs, the scientific group with experts’ cooperation may be more suitable to fight against cancer by solving the existing problems of major cancer diseases.

Through RTTC plenary speeches, interactive round-table discussions and face-to-face meetings, nearly 100 invited speakers from Europe, Asia-pacific and China will share the latest basic and clinical progresses information about, targeting therapy in combination, the global antitumor drug market, the next generation anti-cancer drug research & development and clinical trials, and will introduce the new opportunities for new technologies and instrument to improve the clinical and experimental research. RTTC has effectively enhanced the cooperation among hospitals, institutes and manufacturers.

Agenda

First Day: Nov.15th, 2013(Friday)
Key Session 1:Sino-US Public Healthcare Project: From Innovation to Clinical Application
Key Session 2:Trend of Investment and Financing in the Future of Medical Field

Second Day: Nov.16th, 2013(Saturday)
Plenary Lectures
Session 1: Disease Detection and Stratification for Personalized Cancer Medicine
Session 2:Facing the Challenge:Molecular Diagnostic Market Prospect
Session 3:Prospects and Problems of Targeting and Radiation Therapies
Session 4: Molecular Imaging and Targeting Therapy of Tumor
Session 5:Making the Connections:Effectively Partnering with Clinicians
Session 6:Status of Targeted Drug Therapy and Joint Application

Third Day: Nov.17th, 2013 (Sunday)
Session 7:Research Development and Cooperation of Hospital Central Laboratory
Session 8:From Lab to Clinical:Hospital Central Laboratory Innovation Cooperation
Mode
Session 9:Personalized Oncology and Anticancer Drug Development in Next Generation
Session 10:Clinical Trials of Cancer in China
Session 11:Treatment Compliance Prediction and Prognostic Diagnosis of Cancer
Session 12:Clinical Potential of Tumor Stem Cell for Treating Cancer

Registration

Registration fee Representatives of the companies Academes
Advanced registration
(Apr. 1 to Jul. 31) $799.00 $639.00
On-site registration
(Aug. 1 to Nov. 16) $999.00 $799.00
Note: If the representatives need an official invitation letter after registration, the organizing committee will provide a formal meeting invitation to you.

Register Now

1) Register online: please go to http://www.biotech-instrument.org/en/canhuizhuce/

2) By email: please fill out attached registration form completely,and email it back to Sally@biotechinstrument.org

3) By fax: please fill out attached registration form completely, and fax it to +86-21-5240 0466

 


 

照片 (0)
视频 (0)
下载 (0)




0 评论